In this article, well explore the potential of GLP-1 patches, how they might fit into the broader treatment landscape, and what patients considering metabolic health support should know about the future of these therapies
GLP-1 medications carry risks including pancreatitis, gallbladder disease, and potential thyroid C-cell tumours based on animal studies
Focus on: Beta-glucans: Found in oats and barley
Without a gallbladder, your body handles fat digestion differently, and Mounjaros gastrointestinal side effects can overlap with symptoms you may already be managing post-surgery
Patients discontinuing GLP-1s is likely also driving insurers to avoid covering products in the first place or to drop coverage over time
For patients with diabetes, dyslipidaemia or other relevant conditions, appropriate tests may include renal function, HbA1c, and lipid profiles as clinically indicated and per local protocols